Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday

Apellis Pharmaceuticals (NASDAQ: APLS) shares surged 136.4% to $40.40 after announcing its acquisition by Biogen for $41 per share. Other notable gainers included Centessa Pharmaceuticals (NASDAQ: CNTA), which rose 45.7% to $40.18 following its acquisition announcement by Eli Lilly for up to $47 per share, and Agios Pharmaceuticals (NASDAQ: AGIO), which increased 16.3% to $34.44 after pursuing accelerated FDA approval for its treatment in sickle cell disease.